Seniors Support Transparency For All Drug Pricing Agreements – PCMA Survey
This article was originally published in The Pink Sheet Daily
Executive Summary
More than three-quarters of seniors polled support disclosure by drug manufacturers of all types of pricing agreements, a survey sponsored by the Pharmaceutical Care Management Association indicates
You may also be interested in...
PCMA Launches Ad Campaign On Medicare Formulary Design
Print ad asks "Guess who's coming to dinner?" and features a sumo wrestler representing "the big drug companies." Inside-the-Beltway advertising campaign is designed to ensure that Medicare Rx formulary design permits current market practices, the PBM association says.
Lupus Guidance Suggests Broad Use Of Health-Related Quality Of Life Endpoint
FDA’s draft guidance on systemic lupus erythematosus drug development lists four possible claims that the agency “may be willing to approve”: reduction in disease activity; organ-specific lupus treatment; complete clinical response/remission; and reduction in flares.